Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Naoe Y

Collect these papers and discover other ones on Labmeeting. Learn more.

Runx proteins regulate Foxp3 expression.

+ cite this

+ View Abstract

Bruno L, Mazzarella L, Hoogenkamp M, Hertweck A, Cobb BS, Sauer S, Hadjur S, Leleu M, Naoe Y, Telfer JC, Bonifer C, Taniuchi I, Fisher AG, and Merkenschlager M

The Journal of experimental medicine 206(11):2329-37, 2009 Oct 26 - Who cited this? | PubMed ID: 19841090 | Fulltext

Indispensable Role of the Runx1-Cbfbeta Transcription Complex for In Vivo-Suppressive Function of FoxP3(+) Regulatory T Cells.

+ cite this

+ View Abstract

Kitoh A, Ono M, Naoe Y, Ohkura N, Yamaguchi T, Yaguchi H, Kitabayashi I, Tsukada T, Nomura T, Miyachi Y, Taniuchi I, and Sakaguchi S

Immunity 31(4):609-20, 2009 Oct 16 - Who cited this? | PubMed ID: 19800266 | Fulltext

Chromatin Binding of SRp20 and ASF/SF2 and Dissociation from Mitotic Chromosomes Is Modulated by Histone H3 Serine 10 Phosphorylation.

+ cite this

+ View Abstract

Loomis RJ, Naoe Y, Parker JB, Savic V, Bozovsky MR, Macfarlan T, Manley JL, and Chakravarti D

Molecular cell 33(4):450-61, 2009 Feb 27 - Who cited this? | PubMed ID: 19250906 | Fulltext

Structural basis for gibberellin recognition by its receptor GID1.

+ cite this

+ View Abstract

Shimada A, Ueguchi-Tanaka M, Nakatsu T, Nakajima M, Naoe Y, Ohmiya H, Kato H, and Matsuoka M

Nature 456(7221):520-3, 2008 Nov 27 - Who cited this? | PubMed ID: 19037316 | Fulltext

Cascading suppression of transcriptional silencers by ThPOK seals helper T cell fate.

+ cite this

+ View Abstract

Muroi S, Naoe Y, Miyamoto C, Akiyama K, Ikawa T, Masuda K, Kawamoto H, and Taniuchi I

Nature immunology, 2008 Sep 7 - Who cited this? | PubMed ID: 18776907 | Fulltext

Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development.

+ cite this

+ View Abstract

Setoguchi R, Tachibana M, Naoe Y, Muroi S, Akiyama K, Tezuka C, Okuda T, and Taniuchi I

Science (New York, N.Y.) 319(5864):822, 2008 Feb 8 - Who cited this? | PubMed ID: 18258917 | Fulltext

Repression of interleukin-4 in T helper type 1 cells by Runx/Cbf beta binding to the Il4 silencer.

+ cite this

+ View Abstract

Naoe Y, Setoguchi R, Akiyama K, Muroi S, Kuroda M, Hatam F, Littman DR, and Taniuchi I

The Journal of experimental medicine 204(8):1749, 2007 Aug 6 - Who cited this? | PubMed ID: 17646405 | Fulltext

The role of the Runx transcription factors in thymocyte differentiation and in homeostasis of naive T cells.

+ cite this

+ View Abstract

Egawa T, Tillman RE, Naoe Y, Taniuchi I, and Littman DR

The Journal of experimental medicine 204(8):1945-57, 2007 Aug 6 - Who cited this? | PubMed ID: 17646406 | Fulltext

No association between the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and schizophrenia in Asian populations: Evidence from a case-control study and meta-analysis.

+ cite this

+ View Abstract

Naoe Y, Shinkai T, Hori H, Fukunaka Y, Utsunomiya K, Sakata S, Matsumoto C, Shimizu K, Hwang R, Ohmori O, and Nakamura J

Neuroscience letters 415(2):108-12, 2007 Mar 26 - Who cited this? | PubMed ID: 17267117 | Fulltext

The Orexin 1 Receptor (HCRTR1) Gene as a Susceptibility Gene Contributing to Polydipsia-Hyponatremia in Schizophrenia.

+ cite this

+ View Abstract

Fukunaka Y, Shinkai T, Hwang R, Hori H, Utsunomiya K, Sakata S, Naoe Y, Shimizu K, Matsumoto C, Ohmori O, and Nakamura J

Neuromolecular medicine 9(4):292-7, 2007 - Who cited this? | PubMed ID: 17999203 | Fulltext

FR177391, a new anti-hyperlipidemic agent from Serratia. II. Pharmacological activity of FR177391.

+ cite this

+ View Abstract

Inami M, Kawamura I, Tsujimoto S, Yasuno T, Lacey E, Hirosumi J, Takakura S, Nishigaki F, Naoe Y, Manda T, and Mutoh S

The Journal of antibiotics 58(10):640-7, 2005 Oct - Who cited this? | PubMed ID: 16392680 | Fulltext

Structural characterization of calcineurin B homologous protein 1.

+ cite this

+ View Abstract

Naoe Y, Arita K, Hashimoto H, Kanazawa H, Sato M, and Shimizu T

The Journal of biological chemistry 280(37):32372, 2005 Sep 16 - Who cited this? | PubMed ID: 15987692 | Fulltext

Shared and distinct roles mediated through C-terminal subdomains of acute myeloid leukemia/Runt-related transcription factor molecules in murine development.

+ cite this

+ View Abstract

Fukushima-Nakase Y, Naoe Y, Taniuchi I, Hosoi H, Sugimoto T, and Okuda T

Blood 105(11):4298-307, 2005 Jun 1 - Who cited this? | PubMed ID: 15713794 | Fulltext

Crystallization and preliminary X-ray crystallographic analysis of rat calcineurin B homologous protein 1.

+ cite this

+ View Abstract

Naoe Y, Arita K, Hashimoto H, Kanazawa H, Sato M, and Shimizu T

Acta crystallographica. Section F, Structural biology and crystallization communications 61(Pt 6):612-3, 2005 Jun 1 - Who cited this? | PubMed ID: 16511110 | Fulltext

Marker genes to predict sensitivity to FK228, a histone deacetylase inhibitor.

+ cite this

+ View Abstract

Sasakawa Y, Naoe Y, Sogo N, Inoue T, Sasakawa T, Matsuo M, Manda T, and Mutoh S

Biochemical pharmacology 69(4):603-16, 2005 Feb 15 - Who cited this? | PubMed ID: 15670579 | Fulltext

Structure-based design and synthesis of non-nucleoside, potent, and orally bioavailable adenosine deaminase inhibitors.

+ cite this

+ View Abstract

Terasaka T, Okumura H, Tsuji K, Kato T, Nakanishi I, Kinoshita T, Kato Y, Kuno M, Seki N, Naoe Y, Inoue T, Tanaka K, and Nakamura K

Journal of medicinal chemistry 47(11):2728-31, 2004 May 20 - Who cited this? | PubMed ID: 15139750 | Fulltext

Antitumor efficacy of FK228, a novel histone deacetylase inhibitor, depends on the effect on expression of angiogenesis factors.

+ cite this

+ View Abstract

Sasakawa Y, Naoe Y, Noto T, Inoue T, Sasakawa T, Matsuo M, Manda T, and Mutoh S

Biochemical pharmacology 66(6):897-906, 2003 Sep 15 - Who cited this? | PubMed ID: 12963476 | Fulltext

Effects of FK228, a novel histone deacetylase inhibitor, on tumor growth and expression of p21 and c-myc genes in vivo.

+ cite this

+ View Abstract

Sasakawa Y, Naoe Y, Inoue T, Sasakawa T, Matsuo M, Manda T, and Mutoh S

Cancer letters 195(2):161-8, 2003 Jun 10 - Who cited this? | PubMed ID: 12767524 | Fulltext

Effects of FK228, a novel histone deacetylase inhibitor, on human lymphoma U-937 cells in vitro and in vivo.

+ cite this

+ View Abstract

Sasakawa Y, Naoe Y, Inoue T, Sasakawa T, Matsuo M, Manda T, and Mutoh S

Biochemical pharmacology 64(7):1079-90, 2002 Oct 1 - Who cited this? | PubMed ID: 12234611 | Fulltext

Cerebral endothelial injury in severe head injury: the significance of measurements of serum thrombomodulin and the von Willebrand factor.

+ cite this

+ View Abstract

Yokota H, Naoe Y, Nakabayashi M, Unemoto K, Kushimoto S, Kurokawa A, Node Y, and Yamamoto Y

Journal of neurotrauma 19(9):1007-15, 2002 Sep - Who cited this? | PubMed ID: 12482114 | Fulltext

Effects of FK317, a novel anti-cancer agent, on survival of mice bearing B16BL6 melanoma and Lewis lung carcinoma.

+ cite this

+ View Abstract

Inami M, Kawamura I, Tsujimoto S, Nishigaki F, Matsumoto S, Naoe Y, Sasakawa Y, Matsuo M, Manda T, and Goto T

Cancer letters 181(1):39-45, 2002 Jul 8 - Who cited this? | PubMed ID: 12430177 | Fulltext

Measurements of cortical cellular pH by intracranial tonometer in severe head injury.

+ cite this

+ View Abstract

Yokota H, Yamamoto Y, Naoe Y, Fuse A, Sato H, Unemoto K, and Kurokawa A

Critical care medicine 28(9):3275-80, 2000 Sep - Who cited this? | PubMed ID: 11008992 | Fulltext

Cachexia induction by EL-4 lymphoma in mice and possible involvement of impaired lipoprotein lipase activity.

+ cite this

+ View Abstract

Tsujimoto S, Kawamura I, Inami M, Lacey E, Nishigaki F, Naoe Y, Manda T, and Goto T

Anticancer research 20(5A):3111-6, 2000 - Who cited this? | PubMed ID: 11062730 | Fulltext

Effects of a novel pyridylsulphonyl thiazole derivative, FR115092, on autoimmune and mitomycin C-induced thrombocytopenia in mice.

+ cite this

+ View Abstract

Nishigaki F, Tsujimoto S, Inami M, Matsumoto S, Naoe Y, Kawamura I, Manda T, and Shimomura K

The Journal of pharmacy and pharmacology 51(7):857-65, 1999 Jul - Who cited this? | PubMed ID: 10467963 | Fulltext

Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome in nude mice bearing human melanomas G361 and SEKI.

+ cite this

+ View Abstract

Kawamura I, Lacey E, Inami M, Nishigaki F, Naoe Y, Tsujimoto S, Manda T, and Goto T

Anticancer research 19(5B):4091-7, 1999 - Who cited this? | PubMed ID: 10628359 | Fulltext

Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome induced by colon26 adenocarcinoma in mice.

+ cite this

+ View Abstract

Kawamura I, Lacey E, Yamamoto N, Sakai F, Takeshita S, Inami M, Nishigaki F, Naoe Y, Tsujimoto S, Manda T, Shimomura K, and Goto T

Anticancer research 19(5B):4105-11, 1999 - Who cited this? | PubMed ID: 10628361 | Fulltext

Activation of lipoprotein lipase and inhibition of B16 melanoma-induced cachexia in mice by ponalrestat, an aldose reductase inhibitor.

+ cite this

+ View Abstract

Kawamura I, Yamamoto N, Sakai F, Yamazaki H, Naoe Y, Inami M, Manda T, and Shimomura K

Anticancer research 19(1A):341-8, 1999 - Who cited this? | PubMed ID: 10226565 | Fulltext

FK317, a novel substituted dihydrobenzoxazine, exhibits potent antitumor activity against human tumor xenografts in nude mice.

+ cite this

+ View Abstract

Naoe Y, Inami M, Matsumoto S, Takagaki S, Fujiwara T, Yamazaki S, Kawamura I, Nishigaki F, Tsujimoto S, Manda T, and Shimomura K

Japanese journal of cancer research : Gann 89(12):1306-17, 1998 Dec - Who cited this? | PubMed ID: 10081492 | Fulltext

Anti-cachectic effect of FK317, a novel anti-cancer agent, in colon26 and LX-1 models in mice.

+ cite this

+ View Abstract

Naoe Y, Kawamura I, Inami M, Matsumoto S, Nishigaki F, Tsujimoto S, Manda T, and Shimomura K

Japanese journal of cancer research : Gann 89(12):1318-25, 1998 Dec - Who cited this? | PubMed ID: 10081493 | Fulltext

Different effects of FK317 on multidrug-resistant tumor in vivo and in vitro.

+ cite this

+ View Abstract

Naoe Y, Inami M, Takagaki S, Matsumoto S, Kawamura I, Nishigaki F, Tsujimoto S, Manda T, and Shimomura K

Japanese journal of cancer research : Gann 89(10):1047-54, 1998 Oct - Who cited this? | PubMed ID: 9849584 | Fulltext

Mechanisms for 5-fluorouracil resistance in human colon cancer DLD-1 cells.

+ cite this

+ View Abstract

Inaba M, Naoe Y, and Mitsuhashi J

Biological & pharmaceutical bulletin 21(6):569-73, 1998 Jun - Who cited this? | PubMed ID: 9657039 | Fulltext

Cytotoxic mechanisms of FK317, a new class of bioreductive agent with potent antitumor activity.

+ cite this

+ View Abstract

Naoe Y, Inami M, Kawamura I, Nishigaki F, Tsujimoto S, Matsumoto S, Manda T, and Shimomura K

Japanese journal of cancer research : Gann 89(6):666-72, 1998 Jun - Who cited this? | PubMed ID: 9703365 | Fulltext

Effect of FR143430, a novel cytokine suppressive agent, on adenocarcinoma colon26-induced cachexia in mice.

+ cite this

+ View Abstract

Yamamoto N, Kawamura I, Nishigaki F, Tsujimoto S, Naoe Y, Inami M, Elizabeth L, Manda T, and Shimomura K

Anticancer research 18(1A):139-44, 1998 - Who cited this? | PubMed ID: 9568068 | Fulltext

FK317: a novel substituted dihydrobenzoxazine with potent antitumor activity which does not induce vascular leak syndrome.

+ cite this

+ View Abstract

Naoe Y, Inami M, Matsumoto S, Nishigaki F, Tsujimoto S, Kawamura I, Miyayasu K, Manda T, and Shimomura K

Cancer chemotherapy and pharmacology 42(1):31-6, 1998 - Who cited this? | PubMed ID: 9619755 | Fulltext

Effects of a new non-steroidal 5 alpha-reductase inhibitor, FK143, on the prostate gland in beagle dogs.

+ cite this

+ View Abstract

Inami M, Kawamura I, Naoe Y, Tsujimoto S, Mizota T, Manda T, and Shimomura K

Japanese journal of pharmacology 74(2):187-94, 1997 Jun - Who cited this? | PubMed ID: 9243327 | Fulltext

Reduced activity of anabolizing enzymes in 5-fluorouracil-resistant human stomach cancer cells.

+ cite this

+ View Abstract

Inaba M, Mitsuhashi J, Sawada H, Miike N, Naoe Y, Daimon A, Koizumi K, Tsujimoto H, and Fukushima M

Japanese journal of cancer research : Gann 87(2):212-20, 1996 Feb - Who cited this? | PubMed ID: 8609072 | Fulltext

A new aromatase inhibitor, FR901537. II. Pharmacological and antitumor effects.

+ cite this

+ View Abstract

Oohata N, Kawamura I, Lacey E, Nishigaki F, Matsumoto S, Tsujimoto S, Naoe Y, Manda T, and Shimomura K

The Journal of antibiotics 48(8):763-7, 1995 Aug - Who cited this? | PubMed ID: 7592018 | Fulltext

[Evaluation of angiographic delayed vasospasm due to ruptured aneurysm in comparison with cerebral circulation time measured by IA-DSA].

+ cite this

+ View Abstract

Okada Y, Shima T, Nishida M, Yamane K, Okita S, Hatayama T, Yoshida A, Naoe Y, and Shiga N

No shinkei geka. Neurological surgery 22(5):439-45, 1994 May - Who cited this? | PubMed ID: 8196830 | Fulltext

[Clinicopathoradiological studies in 15 cases of megadolichobasilar anomaly].

+ cite this

+ View Abstract

Okada Y, Shima T, Nishida M, Yamane K, Okita S, Hatayama T, Naoe Y, and Nishida T

No to shinkei = Brain and nerve 46(3):257-62, 1994 Mar - Who cited this? | PubMed ID: 8192941 | Fulltext

Search Google Scholar for Naoe Y

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!